Japanese Pharmaceuticals & Biotech Strong Balance Sheet Stocks

PhoenixBio

Market Cap: JP¥1.5b

Provides contract testing services for medical product development in Japan, the United States, and internationally.

Otsuka Holdings

Market Cap: JP¥5.4t

Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.

Kringle Pharma

Market Cap: JP¥2.3b

Engages in research and develops therapeutic agents for the treatment of intractable diseases in Japan.

CellSource

Market Cap: JP¥5.9b

Engages in the regenerative medicine-related businesses in Japan.

Human Metabolome Technologies

Market Cap: JP¥3.4b

Human Metabolome Technologies, Inc., biotechnology company, develops metabolomics technologies and solutions for drug discovery, diagnosis, and food production in Japan.

Solasia Pharma K.K

Market Cap: JP¥6.0b

Develops, markets, imports, and exports pharmaceutical products and medical devices in Japan, China, South Korea, and internationally.

CanBas

Market Cap: JP¥10.4b

A clinical stage biopharmaceutical company, engages in the basic research and clinical development of anti-cancer drugs.

TMS

Market Cap: JP¥5.3b

Engages in the research and development, manufacture, and sale of drug products, quasi-drugs, drug substances, medical devices, and medical commodities.

Ribomic

Market Cap: JP¥3.4b

Ribomic Inc. discovers and develops pharmaceutical compounds using RNA aptamers in Japan.

Chugai Pharmaceutical

Market Cap: JP¥12.2t

Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.

Veritas In Silico

Market Cap: JP¥2.8b

Engages in the business of small molecule drug discovery and nucleic acid drug discovery targeting mRNA.

Santen Pharmaceutical

Market Cap: JP¥622.6b

Engages in the research and development, manufacturing, and marketing of pharmaceuticals and medical devices in Japan, China, Asia, Europe, the Middle East, Africa, and internationally.

Nippon Shinyaku

Market Cap: JP¥269.9b

Manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally.

Noile-Immune Biotech

Market Cap: JP¥5.1b

Researches and develops CAR-T cells for novel cancer immunotherapies.

PRISM BioLabLTD

Market Cap: JP¥5.0b

Engages in the research and development of pharmaceuticals using its proprietary drug discovery platform technology, PepMetics Technology.

Chordia Therapeutics

Market Cap: JP¥7.4b

A biotech company, engages in research and development of anti-cancer drugs that targets RNA deregulation stress in Japan.

FunPep

Market Cap: JP¥3.0b

Engages in the research and development of pharmaceuticals drugs, functional cosmetics, and medical devices in Japan and internationally.

Kyowa Kirin

Market Cap: JP¥1.3t

Engages in the research, development, manufacturing, and marketing of pharmaceuticals in Japan, the Americas, Europe, Asia, and internationally.

WDB coco

Market Cap: JP¥6.1b

Provides contract and human resource services to pharmaceutical companies in Japan.

KYORIN Pharmaceutical

Market Cap: JP¥65.4b

Through its subsidiaries, researches and develops, manufactures, and sells ethical and generic drugs in Japan and internationally.

J-Pharma

Market Cap: JP¥6.9b

J-Pharma Co., Ltd. is engaged in drug discovery and development, focusing on amino acid transporters as drug targets.

Tsubota Laboratory

Market Cap: JP¥5.6b

Engages in the development and sale of pharmaceuticals and medical devices for the treatment of myopia, dry eyes, presbyopia, and neurological disorders.

ReproCELL

Market Cap: JP¥12.0b

Provides stem cell research and drug discovery services in Japan.

Perseus Proteomics

Market Cap: JP¥2.5b

A drug discovery biotech venture company, develops antibody drugs against cancer and other diseases in Japan.

Modalis Therapeutics

Market Cap: JP¥3.3b

Engages in the research and development of therapeutics to treat patients with serious genetic disorders.

OncoTherapy Science

Market Cap: JP¥7.3b

Engages in research and development of anti-body drugs; and the genome analysis of cancer, liquid biopsy, and development of new immunotherapy in Japan.

MedRx

Market Cap: JP¥3.3b

A pharmaceutical formulation development company, provides pharmaceutical drugs based on the transdermal absorption system in Japan.

Fuji Pharma

Market Cap: JP¥59.2b

Engages in the research and development, manufacture, and marketing of pharmaceutical products in Japan and internationally.

Japan Tissue Engineering

Market Cap: JP¥23.5b

Engages in the regenerative medicine business in Japan.

StemRIM

Market Cap: JP¥17.7b

A biotechnology company, researches and develops regeneration-inducing medicine in Japan and internationally.

Heartseed

Market Cap: JP¥36.3b

Develops and commercializes iPS cell-derived cardiomyocyte replacement therapy for heart failure.

SanBio

Market Cap: JP¥92.2b

Engages in the development, production, and sale of regenerative cell medicines for the central nervous system.

Renascience

Market Cap: JP¥21.3b

Engages in the development and commercialization of pharmaceuticals and medical devices in Japan.

ASKA Pharmaceutical HoldingsLtd

Market Cap: JP¥68.5b

Through its subsidiaries, engages in the pharmaceutical, animal health, and other businesses in Japan.

Cuorips

Market Cap: JP¥30.5b

Engages in the research, development, manufacture, commercialization, and sale of human iPS cell-derived cardiomyocyte sheets.

Stella Pharma

Market Cap: JP¥11.1b

Engages in the research, development, manufacturing, and distribution of pharmaceuticals.